Dr Rachel Byng-Maddick, Consultant Rheumatologist

Dr Rachel Byng-Maddick

Consultant Rheumatologist

Book online
|

Dr Rachel Byng-Maddick BSc, MBBS, PhD, MRCP (rheum)

Consultant Rheumatologist

BSc, MBBS, PhD, MRCP (rheum)

Dr Rachel Byng-Maddick

Consultant Rheumatologist BSc, MBBS, PhD, MRCP (rheum)

Book online
|
BSc, MBBS, PhD, MRCP (rheum)
HCA-Healthcare-UK

Areas of expertise

  • Inflammatory arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and seronegative spondyloarthropathies)
  • Crystal arthritis (including gout)
  • Osteoarthritis
  • Connective tissue disease
  • Osteoporosis
HCA-Healthcare-UK

Address

  • The Lister Hospital

    Chelsea Bridge Road, London, SW1W 8RH

About Dr Rachel Byng-Maddick

GMC number: 6103031

Year qualified: 2004

Place of primary qualification: University of London

Areas of expertise

  • Inflammatory arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and seronegative spondyloarthropathies)
  • Crystal arthritis (including gout)
  • Osteoarthritis
  • Connective tissue disease
  • Osteoporosis

Professional memberships

Royal College of Physicians
General Medical Council
British Society of Rheumatolgy

Articles by Dr Rachel Byng-Maddick

Quantitative characterization of the t cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which is robust, economical, and versatile

Tumor necrosis factor (tnf) bioactivity at the site of an acute cell-mediated immune response is preserved in rheumatoid arthritis patients responding to anti-tnf therapy

Eular16-1770 anti-tnf therapy in patients with rheumatoid arthritis does not attenuate cutaneous tnf activity following a tuberculin skin test

The impact of biological therapy on regulatory t cells in rheumatoid arthritis

Does tuberculosis threaten our ageing populations?

Options for taking time out of specialty training